We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$841M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$752M
3
AAPL icon
Apple
AAPL
+$720M
4
TSLA icon
Tesla
TSLA
+$713M
5
NXPI icon
NXP Semiconductors
NXPI
+$648M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFCS icon
1876
United Fire Group
UFCS
$1.37B
$613K ﹤0.01%
14,450
-2,000
-12% -$85K
NVTR
1877
DELISTED
Nuvectra Corporation Common Stock
NVTR
$612K ﹤0.01%
+82,706
New +$659K
FFBC icon
1878
First Financial Bancorp
FFBC
$3.6B
$610K ﹤0.01%
31,342
– –
MOH icon
1879
Molina Healthcare
MOH
$10.8B
$610K ﹤0.01%
12,229
+35
+0.3% +$1.87K
ESI icon
1880
Element Solutions
ESI
$9.51B
$607K ﹤0.01%
68,393
+9,600
+16% +$89.4K
EXAR
1881
DELISTED
Exar Corporation
EXAR
$606K ﹤0.01%
75,250
+3,000
+4% +$20.1K
NSIT icon
1882
Insight Enterprises
NSIT
$4.54B
$605K ﹤0.01%
23,250
-4,000
-15% -$107K
GPT
1883
DELISTED
Gramercy Property Trust
GPT
$605K ﹤0.01%
21,859
– –
ATRA icon
1884
Atara Biotherapeutics
ATRA
$83.1M
$602K ﹤0.01%
1,070
+606
+131% +$291K
BGC
1885
DELISTED
General Cable Corporation
BGC
$597K ﹤0.01%
47,000
+8,400
+22% +$116K
FOE
1886
DELISTED
Ferro Corporation
FOE
$596K ﹤0.01%
44,560
-9,700
-18% -$129K
TIVO
1887
DELISTED
TIVO INC
TIVO
$596K ﹤0.01%
60,200
– –
PGEN icon
1888
Precigen
PGEN
$2.32B
$594K ﹤0.01%
24,335
+15,639
+180% +$444K
CBU icon
1889
Community Bank
CBU
$3.43B
$593K ﹤0.01%
14,440
-2,190
-13% -$86.9K
MFA
1890
MFA Financial
MFA
$925M
$590K ﹤0.01%
20,287
-4,708
-19% -$132K
FMBI
1891
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$586K ﹤0.01%
33,393
-7,000
-17% -$126K
CHMT
1892
DELISTED
Chemtura Corporation
CHMT
$585K ﹤0.01%
22,170
– –
PFC
1893
DELISTED
Premier Financial Corp. Common Stock
PFC
$582K ﹤0.01%
29,984
+4,800
+19% +$94.5K
SBY
1894
DELISTED
Silver Bay Realty Trust Corp.
SBY
$580K ﹤0.01%
34,083
– –
GCI
1895
DELISTED
Gannett Co., Inc
GCI
$579K ﹤0.01%
41,917
+19,314
+85% +$299K
IPXL
1896
DELISTED
Impax Laboratories, Inc.
IPXL
$578K ﹤0.01%
20,040
– –
CUZ icon
1897
Cousins Properties
CUZ
$4.93B
$577K ﹤0.01%
19,661
– –
WERN icon
1898
Werner Enterprises
WERN
$2.31B
$574K ﹤0.01%
25,002
+1,910
+8% +$47.6K
YDKN
1899
DELISTED
Yadkin Financial Corporation
YDKN
$574K ﹤0.01%
22,895
+5,000
+28% +$125K
CNMD icon
1900
CONMED
CNMD
$1.49B
$573K ﹤0.01%
12,000
– –
74 75
76
77 78

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.